New York Times  Aug 26  Comment 
Raptor Pharmaceuticals has raised $5 million, which will go towards late-stage drug candidates and completing a proposed merger with TorreyPines Therapeutics.
Reuters  Jul 28  Comment 
* Raptor stockholders to own 95 pct stake in combined company
FierceBiotech  Jun 1  Comment 
With no white knight appearing from stage left with a buyout offer, the board at TorreyPines Therapeutics has decided to call it quits and join the ranks of the liquidated. The decision to shutter the company comes three years after TorreyPines...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki